|
- Automated 3D Analysis Of Large Brain MRI Databases
|
Chapter 25: PDF file |
- In Vivo Magnetic Resonance Spectroscopy Studies Of The Glutamate And GABA Neurotransmitter Cycles And Functional Neuroenergetics
- Douglas L. Rothman, Fahmeed Hyder, Nicola Sibson, Kevin L. Behar, Graeme F. Mason, Jun Shen, Ognen A. C. Petroff And Robert G. Shulman
|
Chapter 26: PDF file |
- The Spatial, Temporal, And Interpretive Limits Of Functional MRI
|
Chapter 27: PDF file |
- Diffusion Tensor Imaging
- Nikos Makris, G. M. Papadimitriou, A. J. Worth, Bruce G. Jenkins, L. Garrido, A. Gregory Sorensen, V. J. Wedeen, David S. Tuch, O. Wu, Merit E. Cudkowicz, V. S. Caviness Jr., B. R. Rosen And David N. Kennedy
|
Chapter 28: PDF file |
- Activation Paradigms In Affective And Cognitive Neuroscience: Probing The Neuronal Circuitry Underlying Mood And Anxiety Disorders
|
Chapter 29: PDF file |
- Interactions Among Neuronal Systems Assessed With Functional Neuroimaging
- Christian Büchel And Karl Friston
|
Chapter 30: PDF file |
- Measuring Brain Connectivity With Functional Imaging And Transcranial Magnetic Stimulation (TMS)
- Mark S. George And Daryl E. Bohning
|
Chapter 31: PDF file |
- In Vivo Molecular Imaging: Ligand Development And Research Applications
- Masahiro Fujita And Robert B. Innis
|
Chapter 32: PDF file |
- Event-Related Potentials And Magnetic Fields In The Human Brain
- Steven A. Hillyard And Marta Kutas
|
|
SECTION 4: DRUG DISCOVERY AND EVALUATION |
- Drug Discovery And Evaluation
|
Chapter 33: PDF file |
- The Role Of Preclinical Models In The Development Of Psychotropic Drugs
- Mark A. Geyer And Athina Markou
|
Chapter 34: PDF file |
- Proof Of Concept: Functional Models For Drug Development In Humans
- Dean F. Wong, William Z. Potter And James R. Brasic
|
Chapter 35: PDF file |
- Ethical Aspects Of Neuropsychiatric Research With Human Subjects
- Debra A. Pinals And Paul S. Appelbaum
|
Chapter 36: PDF file |
|
Chapter 37: PDF file |
- Pharmacogenomics And Personalized Therapeutics In Psychiatry
- Vural Özdemir, Vincenzo S. Basile, Mario Masellis, Pierandrea Muglia And James L. Kennedy
|
Chapter 38: PDF file |
- Pharmacokinetics, Pharmacodynamics, And Drug Disposition
- David J. Greenblatt, Lisa L. Von Moltke, Jerold S. Harmatz And Richard I. Shader
|
Chapter 39: PDF file |
- The Role Of Pharmaceuticals In Mental Health Care Outcomes
- Ramin Mahmoud, Chris M. Kozma, C. E. Reeder, Amy Grogg And Brian Meissner
|
Chapter 40: PDF file |
- Issues In Clinical Trial Designs
|
|
SECTION 5: DISORDERS OF DEVELOPMENT |
|
Chapter 41: PDF file |
- The Molecular And Cellular Genetics Of Autism
- Thomas H. Wassink, James S. Sutcliffe, Veronica J. Vieland And Joseph Piven
|
Chapter 42: PDF file |
- Current And Emerging Therapeutics Of Autistic Disorder And Related Pervasive Developmental Disorders
|
Chapter 43: PDF file |
- Pathophysiology Of Attention-Deficit/Hyperactivity Disorder
- Stephen V. Farone And Joseph Biederman
|
Chapter 44: PDF file |
- Learning Disorders
- C. Keith Conners And Ann C. Schulte
|
Chapter 45: PDF file |
- Psychosis In Childhood And Its Management
- Paramjit T. Joshi And Kenneth E. Towbin
|
Chapter 46: PDF file |
- Behavioral Phenotypes Of Neurodevelopmental Disorders: Portals Into The Developing Brain
|
|
SECTION 6: SCHIZOPHRENIA AND RELATED DISORDERS |
- Schizophrenia And Related Disorders
|
Chapter 47: PDF file |
- Schizophrenia: Course Over The Lifetime
- Philip D. Harvey And Michael Davidson
|
Chapter 48: PDF file |
- Neurocognitive Functioning In Patients With Schizophrenia: An Overview
- Terry E. Goldberg And Michael F. Green
|
Chapter 49: PDF file |
- Molecular And Population Genetics Of Schizophrenia
- Ming T. Tsuang And Michael J. Owen
|
Chapter 50: PDF file |
(责任编辑:泉水)